[Amyloidosis].
Homma
Noriyuki
N
Department of Internal Medicine, Niigata Prefectural Shibata Hospital.
D000686:Amyloidosis / Q000145:classification / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001053:Apolipoproteins / Q000097:blood; D001536:Bence Jones Protein; D003078:Colchicine / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D018380:Hematopoietic Stem Cell Transplantation; D017583:Hemodiafiltration; D006801:Humans; D007147:Immunoglobulin Light Chains; D000069285:Infliximab; D008558:Melphalan / Q000008:administration & dosage; D008567:Membranes, Artificial; D008851:Micropore Filters; D011228:Prealbumin; D011239:Prednisolone / Q000008:administration & dosage; D006435:Renal Dialysis; D000685:Serum Amyloid A Protein
D000911:Antibodies, Monoclonal; D001053:Apolipoproteins; D007147:Immunoglobulin Light Chains; D008567:Membranes, Artificial; D011228:Prealbumin; D000685:Serum Amyloid A Protein; D001536:Bence Jones Protein; D011239:Prednisolone; D000069285:Infliximab; D008558:Melphalan; D003078:Colchicine